RT Journal Article
SR Electronic
T1 Disparities in Time to Treatment for Breast Cancer
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 5813
OP 5818
DO 10.21873/anticanres.16088
VO 42
IS 12
A1 SUKNIAM, KULKAEW
A1 KASBI, ALI ABBASZADEH
A1 ASHARY, MOHAMMED ALI
A1 POPP, KYLE
A1 ATTWOOD, KRISTOPHER
A1 GEORGE, ANTHONY
A1 GABRIEL, EMMANUEL
YR 2022
UL http://ar.iiarjournals.org/content/42/12/5813.abstract
AB Background/Aim: This study aimed to identify the demographic/socioeconomic factors associated with disparities in time to breast cancer treatment. Patients and Methods: We conducted an analysis of breast cancer patients from the National Cancer Database, 2008-2019. Time intervals from diagnosis to surgery, radiation, and chemotherapy were compared based on age, sex, race, and socioeconomic status. Results: A total of 715,210 patients with breast cancer were included. Overall, Hispanic patients had the longest times to surgery, radiation, and chemotherapy compared to non-Hispanic patients (surgery 73.3 vs. 53.8 days, radiation 177.2 vs. 136.9 days, chemotherapy 83.0 vs. 66.5 days, all p<0.01). Similarly, black patients, those who were uninsured, and those with lower income (<$63,000) had the longest times to treatment. Conclusion: We identified several racial/socioeconomic disparities in time to treatment. Further investigation into the causes of these disparities is of increasing importance to address inequities in breast cancer care.